Showing results (121-130 of 206) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|September 6, 2024
Polymyxins retain in vitro activity and in vivo efficacy against "resistant" Acinetobacter baumannii strains when tested in physiological conditionsJennifer Rubio, Jun Yan, Sarah Miller, et al.
Medical Mycology|March 23, 2012
Risk factors for mortality in patients with mucormycosisBrad Spellberg, Dimitrios P Kontoyiannis, David Fredricks, et al.
Human Vaccines & Immunotherapeutics|April 20, 2017
Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infectionBrian L Cheng, Travis B Nielsen, Paul Pantapalangkoor, et al.
Pediatric Blood & Cancer|February 24, 2021
The incidence and risk factors for venous thromboembolism in adolescent and young adult oncology patientsWendy Hsiao, Emily Krava, Choo Phei Wee, et al.
Chemical Communications (Cambridge, England)|June 7, 2018
Hetero-assembly of a dual β-amyloid variant peptide systemJason Candreva, Edward Chau, Edwin Aoraha, et al.
Biochemical and Biophysical Research Communications|August 28, 2021
Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivativeEdward Chau, Hyunjoo Kim, Jineun Shin, et al.
The New England Journal of Medicine|April 9, 2005
Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los AngelesLoren G Miller, Francoise Perdreau-Remington, Gunter Rieg, et al.
The Journal of Clinical Investigation|May 21, 2010
The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic miceMingfu Liu, Brad Spellberg, Quynh T Phan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2008
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaHelen W Boucher, George H Talbot, John S Bradley, et al.
The Journal of Antimicrobial Chemotherapy|September 23, 2011
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trialBrad Spellberg, Ashraf S Ibrahim, Peter V Chin-Hong, et al.
Pageof 21